The value of pulse cyclophosphamide in ANCA-associated vasculitis: meta-analysis and critical reviewDE GROOT, Kirsten; ADU, Dwomoa; SAVAGE, Caroline O. S et al.Nephrology, dialysis, transplantation (Print). 2001, Vol 16, Num 10, pp 2018-2027, issn 0931-0509Article

Risk Factors for Relapse of Antineutrophil Cytoplasmic Antibody―Associated VasculitisWALSH, Michael; FLOSSMANN, Oliver; BERDEN, Annelies et al.Arthritis and rheumatism. 2012, Vol 64, Num 2, pp 542-548, issn 0004-3591, 7 p.Article

Treatment of refractory Wegener's granulomatosis with antithymocyte globulin (ATG): An open study in 15 patientsSCHMITT, Wilhelm H; HAGEN, E. Christiaan; NEUMANN, Irmgard et al.Kidney international. 2004, Vol 65, Num 4, pp 1440-1448, issn 0085-2538, 9 p.Article

EULAR recommendations for the management of primary small and medium vessel vasculitisMUKHTYAR, C; GUILLEVIN, L; MERKEL, P. A et al.Annals of the rheumatic diseases. 2009, Vol 68, Num 3, pp 310-317, issn 0003-4967, 8 p.Article

Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trialsSUPPIAH, Ravi; HADDEN, Robert D. M; BATRA, Rajbir et al.Rheumatology (Oxford. Print). 2011, Vol 50, Num 12, pp 2214-2222, issn 1462-0324, 9 p.Article

Long-term patient survival in ANCA-associated vasculitisFLOSSMANN, Oliver; BERDEN, Annelies; MUKHTYAR, Chetan et al.Annals of the rheumatic diseases. 2011, Vol 70, Num 3, pp 488-494, issn 0003-4967, 7 p.Article

Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitisDE GROOT, Kirsten; RASMUSSEN, Niels; BACON, Paul A et al.Arthritis and rheumatism. 2005, Vol 52, Num 8, pp 2461-2469, issn 0004-3591, 9 p.Article

Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitisJAYNE, David R. W; GASKIN, Gill; WESTMAN, Kerstin W et al.Journal of the American Society of Nephrology. 2007, Vol 18, Num 7, pp 2180-2188, issn 1046-6673, 9 p.Article

A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodiesJAYNE, David; RASMUSSEN, Niels; GROSS, Wolfgang et al.The New England journal of medicine. 2003, Vol 349, Num 1, pp 36-44, issn 0028-4793, 9 p.Article

Incidence of malignancy in patients treated for antineutrophil cytoplasm antibody-associated vasculitis: follow-up data from European Vasculitis Study Group clinical trialsHEIJL, C; HARPER, L; FLOSSMANN, O et al.Annals of the rheumatic diseases. 2011, Vol 70, Num 8, pp 1415-1421, issn 0003-4967, 7 p.Article

Rituximab versus Cyclophosphamide in ANCA-Associated Renal VasculitisJONES, Rachel B; COHEN TERVAERT, Jan Willem; WALSH, Dorothy et al.The New England journal of medicine. 2010, Vol 363, Num 3, pp 211-220, issn 0028-4793, 10 p.Article

EULAR recommendations for the management of large vessel vasculitisMUKHTYAR, C; GUILLEVIN, L; MERKEL, P. A et al.Annals of the rheumatic diseases. 2009, Vol 68, Num 3, pp 318-323, issn 0003-4967, 6 p.Article

EULAR recommendations for conducting clinical studies and/ or clinical trials in systemic vasculitis : focus on anti-neutrophil cytoplasm antibody-associated vasculitisH, Bernhard; FLOSSMANN, Oliver; SCOTT, David G. I et al.Annals of the rheumatic diseases. 2007, Vol 66, Num 5, pp 605-617, issn 0003-4967, 13 p.Article

Chances of renal recovery for dialysis-dependent ANCA-associated glomerulonephritisDE LIND VAN WIJNGAARDEN, Robert A. F; HAUER, Herbert A; BAJEMA, Ingeborg M et al.Journal of the American Society of Nephrology. 2007, Vol 18, Num 7, pp 2189-2197, issn 1046-6673, 9 p.Article

Determinants of outcome in ANCA-associated glomerulonephritis: A prospective clinico-histopathological analysis of 96 patientsHAUER, Herbert A; BAJEMA, Ingeborg M; VAN HOUWELINGEN, Hans C et al.Kidney international. 2002, Vol 62, Num 5, pp 1732-1742, issn 0085-2538Conference Paper

Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis : a systematic review by the European League Against Rheumatism systemic vasculitis task forceMUKHTYAR, C; FLOSSMANN, O; MERKEL, P. A et al.Annals of the rheumatic diseases. 2008, Vol 67, Num 7, pp 1004-1010, issn 0003-4967, 7 p.Article

Mycophenolate Mofetil vs Azathioprine for Remission Maintenance in Antineutrophil Cytoplasmic Antibody―Associated Vasculitis: A Randomized Controlled TrialHIEMSTRA, Thomas F; WALSH, Michael; PAGNOUX, Christian et al.JAMA, the journal of the American Medical Association. 2010, Vol 304, Num 21, pp 2381-2388, issn 0098-7484, 8 p.Article

Pulse Ilersus Daily Oral Cyclophosphamide for Induction of Remission in Antineutrophil Cytoplasmic Antibody―Associated Vasculitis: A Randomized TrialDE GROOT, Kirsten; HARPER, Lorraine; TESAR, Vladimir et al.Annals of internal medicine. 2009, Vol 150, Num 10, pp 670-680, issn 0003-4819, 11 p.Article

Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis : A prospective analysis of 100 patients with severe renal involvementDE LIND VAN WIJNGAARDEN, Robert A. F; HAUER, Herbert A; BRUIJN, Jan A et al.Journal of the American Society of Nephrology. 2006, Vol 17, Num 8, pp 2264-2274, issn 1046-6673, 11 p.Article